Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Daily News

IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication

L.A. McKeown

December 03, 2024

News Conference News SCAI 2024

Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows

L.A. McKeown

May 06, 2024

News Conference News ISET 2024

Venous Stents: How to Choose Among the Wealth of Options

Caitlin E. Cox

January 26, 2024

News Conference News TCT 2022

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

L.A. McKeown

September 17, 2022

News Daily News

FDA Approves Two Additional Indications for Rivaroxaban in Children

L.A. McKeown

December 21, 2021

News Industry News

Medtronic Venous Stent Recieves U.S. FDA Approval to Treat Venous Outflow Obstruction

October 26, 2020

News Daily News

Abre Venous Stent Meets 30-Day, 1-Year Targets in Pivotal IDE Trial

Caitlin E. Cox

June 18, 2020

News Conference News ISET 2020

Venous Stents: Long-term Follow-up Plus a New Contender

Caitlin E. Cox

January 24, 2020

News Conference News VIVA 2019

Future Pulmonary Embolism Interventions: Wild West or Working Together?

L.A. McKeown

November 14, 2019

News Daily News

Interventional Options and Future Directions for Acute PE: New AHA Statement

Todd Neale

October 07, 2019

News Daily News

Vici Venous Stent Receives FDA Approval for Iliofemoral Obstructive Disease

L.A. McKeown

May 06, 2019

News Industry News

Boston Scientific Receives U.S. FDA Approval for The VICI VENOUS STENT™ System

May 06, 2019

News Conference News ISET 2019

Vici Venous Stent Shows Good Primary Patency, Few MAE by 12 Months: VIRTUS

Caitlin E. Cox

February 08, 2019

News Features

Top News in Endovascular Therapy: 2018

L.A. McKeown

December 28, 2018

Attacking DVT With Drug-Device Combo Does Not Reduce Postthrombotic Syndrome

News Conference News VIVA 2018

VERNACULAR: A Novel Venous Stent Shows Promise for Treatment of Iliofemoral Occlusive Disease

L.A. McKeown

November 08, 2018

News Daily News

Questions Over Risk-Benefit Balance for IVC Filters Still Vex Clinicians

Caitlin E. Cox

November 17, 2016

Advertisement

IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication

Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows

Venous Stents: How to Choose Among the Wealth of Options

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

FDA Approves Two Additional Indications for Rivaroxaban in Children

Medtronic Venous Stent Recieves U.S. FDA Approval to Treat Venous Outflow Obstruction

Abre Venous Stent Meets 30-Day, 1-Year Targets in Pivotal IDE Trial

Venous Stents: Long-term Follow-up Plus a New Contender

Future Pulmonary Embolism Interventions: Wild West or Working Together?

Interventional Options and Future Directions for Acute PE: New AHA Statement

Vici Venous Stent Receives FDA Approval for Iliofemoral Obstructive Disease

Boston Scientific Receives U.S. FDA Approval for The VICI VENOUS STENT™ System

Vici Venous Stent Shows Good Primary Patency, Few MAE by 12 Months: VIRTUS

Top News in Endovascular Therapy: 2018

VERNACULAR: A Novel Venous Stent Shows Promise for Treatment of Iliofemoral Occlusive Disease

Questions Over Risk-Benefit Balance for IVC Filters Still Vex Clinicians

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content